This is still much too negative in my personal view.

New Post Public Reply Private Reply Replies (0) Message Board
Zolis_onkel FanMail #34448
748
This is still much too negative in my personal view.

AE37 development. It is very expensive to run a phase III clinical trial (phase II being successfully completed), and GNBT simply does not have the funding for. Hence the attempt to raise money through the NGIO IPO, which seems to be blocked for at least one year now by the SEC, who seems to keep investigating the company, starting with that deep dive in the 2019 10-K, and whatever else is currently going on.
Oral-Lyn development. Identical situation. It was very unfortunate that the FDA refused the first application for market approval. Then they did the reformulation in the lab, and now it requires another round of phase III clinical trials, which Joe repeatedly said (I personally asked such questions during more than one CC) that it is his intention to run the required clinical trials as soon as other parts of the company (e.g. Olaregen throuch Excellegen sales) have generated the required funding.
Excellegen sales. You actually are aware that we have been in a pandemic in the last 2 years. And again it was very unfortunate, and surely not Joe's or Olaregen's fault, that shortly after the received the VA hospital's holding company approval and sales numbers just started to ramp up, that all VA hospitals were shut down and thus Olaregen's business with them was shut down again.
General lack of communication from the companies to us shareholders. I think I made my standpoint very clear. It is obvious that the company is ready and willing to communicate with us. As a clear indication that this is so, I understand Todd's quick responses to a lot of emails with the message "we are currently not able to publish updates". So it has very little to do with not being willing to or intentionally wanting to leave us out in the cold and rain, but that they are - for some/whatever reason - currently NOT ABLE to do so. Someone/-thing is not allowing them to do so, or terrible consequences will apply.

I think you get my point, and I do not need to continue. It is very easy to criticize Joe's leadership and I am the last to glorify his achievements, however, I do not think that your blaming everything on him personally, is by no means fair neither.
Again, as mentioned before, I do not have more knowledge than anybody else on here, so especially the last part about communication or the lack thereof is, of course, only my assumption. But your "the sky is falling" message contain a lot of (negative) assumptions as well. So why not just give them the benefit of a doubt? And assume that the current situation is actually not their fault, and when I add 2 and 2 together, at least to me, this really sounds like it.

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

GAC's Green Push Unveils 3rd Showroom in Casablanca

Updated Category News Views 146

Pushing Through North Africa's Automotive Shift Well, looks like GAC is showing they're not just dabbling in North Africa—they're planting some sturdy roots in that rocky soil. Opening their third showroom in Casablanca, GAC isn't just settling for sidelines. They're step-in-the-ring serious about carving their name on North African roads. This isn't some skin-deep...

Continue Reading
B2K's Comeback with ECLIPSE Breaks Records

Updated Category News Views 59

Resurgence in the R&B World Well, if you told me B2K would make a grand return and rock the charts after 24 years, I'd have laughed. But it's happening—like a seasoned player making a comeback in overtime. The platinum-selling R&B group B2K launched a new album, 'ECLIPSE,' tied to their 'Boys 4 Life Tour.' The Innovative Marketing Strategy In a move that might just...

Continue Reading
Innovative Towel Keeps Beachgoers Relaxed and Happy

Updated Category News Views 48

Making Waves at the Beach, Literally Ever been lounging at the beach, wrestling with a rebellious towel that refuses to stay put? A West Coast inventor's tackled that pesky problem head-on with their latest creation: the SECURE LOUNGE TOWEL. From sunny California, this game-changing towel hits you with some serious brainwaves of convenience, keeping that sandy mess at bay...

Continue Reading
Willamette Valley's Q3 Struggle: Revenue Gains Amid Losses

Updated Category News Views 8

Navigating the Q3 Highs and Lows When you look at Willamette Valley Vineyards, it feels like they're stuck on a tricky grapevine. Their Q3 results for 2026 dropped like a brick, showing a $0.33 loss per share. It's a carbon copy of last year's blues, without any sweet surprise. Now don't get me wrong, the 6.6% revenue bump is a peach, but all we got was a slightly rosier...

Continue Reading
Dexter Bowling BVL Event Series Honors Veterans

Updated Category News Views 29

A Humble Roll to Honor Service Now, here's a heartwarming tale to chew over your morning coffee: Dexter Bowling is teaming up with the Bowlers to Veterans Link (BVL) for some feel-good festivities this holiday season. Beginning December, four special bowling events are rolling out across the U.S., designed just for veterans to connect over the camaraderie of spare strikes...

Continue Reading
UN Urges Real Progress on Climate at COP31 Summit

Updated Category News Views 36

When it comes to global climate action, meetings like the COP31 summit aren’t just another day in the office. Today, in Antalya, Türkiye, the talk was big, but the stakes are even bigger as business and UN leaders grappled with the nagging gap between corporate commitments and actual emissions reductions. The Urgency of 1.5°C Folks, we're skating on thin ice here with...

Continue Reading
IOS Chicks to Shine on 'All Access' with Andy Garcia

Updated Category News Views 61

How Industrial Outdoor Storage Shapes Our World You drive by them every day, those sprawling lots of trucks and containers—you might not even give them a second glance. But they're the backbone of commerce, the unsung heroes ensuring everything runs like clockwork. IOS Chicks, a trailblazing all-women commercial real estate team, is slated to unravel this world on 'All...

Continue Reading
ICEYE's Role in Poland's Space Resilience Revamp

Updated Category News Views 130

Improving Poland's Emergency Response These days, storms, fires, and floods seem relentless, each disaster knocking harder on the doors of communities worldwide. But Poland's upping the ante, thanks to ICEYE teaming up with Civil Security Hub Poland (CS Hub PL). In an era where data is every bit as crucial as the fire trucks, this partnership is like the cavalry for...

Continue Reading
Innovent Unveils IAR177: A New Era In Rheumatology

Updated Category News Views 52

Setting the Stage for Rheumatic Disease Breakthroughs Innovent Biologics is coming out of the gates hot with its recent presentation at the ACR Convergence 2026, delivering some jaw-dropping preclinical data on its fledgling bispecific antibody, IAR177. Situated in Orlando, this showcase sounds like a real advancement in tackling the uphill battle of rheumatic diseases....

Continue Reading
Suzhou's Rich History: Restoring Ancient Buildings

Updated Category News Views 77

Historic Homes in Suzhou: A Revival Story The ancient city of Suzhou, with its black-tiled roofs and whitewashed walls, is undergoing an unprecedented transformation. This isn't just about slapping a fresh coat of paint or fixing leaky roofs. No, it's about breathing new vitality into dilapidated residences that have withstood the test of time, yet have been neglected...

Continue Reading

Top 5 Most Recently Viewed Articles

Nipocalimab's Unique Design for IgG-Driven Diseases Explored

Updated Category News Views 254

Nipocalimab: A Breakthrough in Treating IgG-Driven Diseases Nipocalimab has emerged as a promising investigational treatment in the realm of IgG-driven alloantibody and autoantibody diseases. Recent results affirm its high-affinity binding characteristics and immunoselective properties. This groundbreaking monoclonal antibody has been shown to significantly reduce IgG...

Continue Reading
FTI Consulting Achieves Robust Earnings Despite Market Challenges

Updated Category News Views 64

FTI Consulting Reports Third Quarter Financial Results FTI Consulting, Inc. (NYSE: FCN) recently announced its financial performance for the third quarter, presenting a noteworthy achievement with earnings of $926 million, marking an increase compared to the previous year. This growth reflects the company's resilience and capacity to adapt amidst fluctuating market...

Continue Reading
FutureFuel Secures Key Approval for Clean Fuel Production

Updated Category News Views 331

FutureFuel Achieves Excise Tax Registration Approval FutureFuel Corp. (NYSE: FF), a leading player in the manufacturing of custom and performance chemicals and biofuels, has recently celebrated a significant success. The company has received its Excise Tax Registration approval from the Internal Revenue Service (IRS). This vital registration marks the first step towards...

Continue Reading
Natural Gas Services Group Increases 2024 EBITDA Guidance

Updated Category News Views 92

Natural Gas Services Group Announces Strong Q3 2024 Results Natural Gas Services Group, Inc. (NYSE: NGS), a prominent provider in the natural gas compression industry, has released its financial results for the third quarter ending September 30, 2024. The company reported significant growth in rental revenue, cash flow from operating activities, and net income, signifying...

Continue Reading
Apple's Leap Forward: C2 Modem Testing Signals 5G Advances

Updated Category News Views 331

Apple Inc. Enters a New Era with C2 Modem Testing Apple Inc. (NASDAQ: AAPL) is taking significant steps in advancing its connectivity technology by reportedly testing its second-generation C2 modem for the upcoming iPhone models. Latest Developments in Modem Technology Recently, a reliable source on X, previously known as Twitter, revealed that Apple is currently in the...

Continue Reading